Pharma money has been influential in various organizations, including universities, medical companies, and patient advocacy groups. Public Citizen reported that from 2010-2022, the drug industry provided at least $6 billion in grants to over 20,000 organizations, raising concerns about conflicts of interest. Examples include the American Heart Association and the American Cancer Society, which received significant funding. While some groups claim that the funds do not influence their advocacy, there are concerns about transparency and possible influence on policies that drugmakers oppose. Transparency and accountability on the part of patient advocacy groups regarding their funding sources have been called for.
Source link
Millions of Dollars Flow From Pharma to Patient Advocacy Groups
